1. Halioua B, Cribier B,FreyM, Tan J.Feelings of stigmatization in patients with rosacea.J Eur Acad Dermatol Venereol 2017 ; 31 : 163-8.
2. Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea:recommendations from the global ROSaceaCOnsensus (ROSCO) panel. Br J Dermatol 2017 ; 176: 431-8.
3. Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSaceaCOnsensus 2019 panel. Br J Dermatol 2020 ; 182 : 1269-76.
4. Cribier B. Rosacea under the microscope: characteristic histological findings. J Eur Acad DermatolVenereol 2013 ; 27: 1336-43.
5. Cribier B. Rosacea: Treatment targets based on new physiopathology data. Ann Dermatol Venereol 2022 ; 149: 99-107.
6. Second J, Severac F, Paix A, Cribier B.Rhinophyma is associated withalcohol intake. J Am Acad Dermatol 2019 ; 81: 249-50.
7. Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol 2017 ; 176: 465-71.
8. van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol 2019 ; 181: 65-79.
9. Le Cleach L, Cribier B. New evidence but still unmet medical needs in rosacea treatment. Br J Dermatol 2019 ; 181 : 11-2.
10. Sobkowska D, Szałapska A, Pawlaczyk M, et al. The Role of Cosmetology in an Effective Treatment ofRosacea: A Narrative Review. Clin Cosmet Investig Dermatol 2023 ; 16: 1419-30.